A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey

Bor, Serhat; Dağlı, Ülkü; Sarer, Banu; Gürel, Selım; Tözün, Nurdan; Sıvrı, Bülent; Akbaş, Türkay; Şahın, Burhan; Memık, Faruk; Batur, Yücel

doi:10.4318/tjg.2011.0209

Cited by 9 publications

(8 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a retrospective multicenter study conducted in Turkey on 1339 NVUGIB patients, more than half of these patients were noted to have comorbidities, including cardiovascular diseases (36,5%) and DM (10,1%) at most. 20 Also in our study, three out four patients suffered comorbidities. In accordance with general population, HT (41,4%), coronary arter disease (28,4%) and DM (15,5%) were recorded.…”

Section: Resultssupporting

confidence: 53%

Nonvarisial Üst Gastrointestinal Sistem Kanamalarında Klinik Gidiş ve Nötrofil-Lenfosit Oranı ve Lökosit Sayısı Arasındaki İlişkinin Değerlendirilmesi

Kandemır

Sule²,

Yavaşoğlu³

et al. 2018

Sakarya Medical Journal

View full text Add to dashboard Cite

show abstract

Section: Resultssupporting

confidence: 53%

Nonvarisial Üst Gastrointestinal Sistem Kanamalarında Klinik Gidiş ve Nötrofil-Lenfosit Oranı ve Lökosit Sayısı Arasındaki İlişkinin Değerlendirilmesi

Kandemır

Sule²,

Yavaşoğlu³

et al. 2018

Sakarya Medical Journal

View full text Add to dashboard Cite

show abstract

“…[21] In a study from Turkey, mean duration of hospital stay for the patients with NVUGIB was 7.0 ± 5.7 days. [19] In our study, patients receiving drugs promoting peptic ulcer bleeding were older than the others. It is interesting that mean duration of hospital stay was not significantly different between these two groups.…”

Section: Discussionmentioning

confidence: 72%

“…[18] In our study, a total of 199 patients who were admitted to hospital for NVUGIB were included, with a mean age of 59.9 ± 18.5 years, of whom 19.1% were older than 80 years, 67.3% were men and comorbid diseases were observed in 58.8% of total patients, similar to other studies. [171819]…”

Section: Discussionmentioning

confidence: 99%

Impact of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs on hospital outcomes in patients with peptic ulcer bleeding

Solakoğlu

Köseoğlu

Atalay

et al. 2014

Saudi J Gastroenterol

View full text Add to dashboard Cite

Background/Aims:There are a limited number of studies including the impact of antiplatelet drugs use on hospital outcomes for nonvariceal upper gastrointestinal bleeding. The aim of this study was to determine the effect of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs upon hospital outcomes in patients with peptic ulcer bleeding.Materials and Methods:The patients under treatment with antiaggregant, anticoagulant or non-steroidal anti-inflammatory drugs were categorized as exposed group (n = 118) and the patients who were not taking any of these drugs were categorized as non-exposed group (n = 81). We analyzed the data of drug intake, comorbid disease, blood transfusion, duration of hospital stay, Blatchford/total Rockall score and diagnosis of patients.Results:In total, 199 patients were included. Of these 59.3% (exposed group) were taking drugs. The patients in exposed group were significantly older than those in non-exposed group (62.9 ± 17.3 years; 55.5 ± 19.3 years, P = 0.005, respectively). Mean number of red blood cell units transfused (2.21 ± 1.51; 2.05 ± 1.87, P = 0.5), duration of hospital stay (3.46 ± 2.80 days; 3.20 ± 2.30 days, P = 0.532) and gastric ulcer rate (33% vs 23.4%, P = 0.172) were higher in exposed group than in non-exposed group but the differences were not statistically significant. Total Rockall and Blatchford scores of the patients were significantly higher in exposed group than in non-exposed group (3.46 ± 1.72 vs 2.94 ± 1.87, P = 0.045; 10.29 ± 3.15 vs 9.31 ± 3.40, P = 0.038).Conclusıon:Our study has shown that anticoagulants, antiaggregants and nonsteroidal anti-inflammatory drugs do not effect duration of hospital stay, red blood cell transfusion requirement and rebleeding for peptic ulcer bleeding.

show abstract

“…As for risk factors for 30-day rebleeding, a large prospectively followed population of 1,264 patients hospitalized with severe peptic ulcer bleedings was conducted (6). The study demonstrated that the ulcer size (≥10 mm), a high-risk stigmata (Forrest Ia to IIb), in-patient start of bleeding, and prior GI bleeding were the risk factors for worse outcome.…”

Section: Original Articlementioning

confidence: 99%

Risk factors of the rebleeding according to the patterns of nonvariceal upper gastrointestinal bleeding

Nam

Jeon²,

Cho³

et al. 2017

Turk J Gastroenterol

View full text Add to dashboard Cite

A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey

Cited by 9 publications

References 11 publications

Nonvarisial Üst Gastrointestinal Sistem Kanamalarında Klinik Gidiş ve Nötrofil-Lenfosit Oranı ve Lökosit Sayısı Arasındaki İlişkinin Değerlendirilmesi

Nonvarisial Üst Gastrointestinal Sistem Kanamalarında Klinik Gidiş ve Nötrofil-Lenfosit Oranı ve Lökosit Sayısı Arasındaki İlişkinin Değerlendirilmesi

Impact of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs on hospital outcomes in patients with peptic ulcer bleeding

Risk factors of the rebleeding according to the patterns of nonvariceal upper gastrointestinal bleeding

Contact Info

Product

Resources

About